Through exploring the various related published research works, a series of studies and explorations are currently focused on inhibiting the poor prognostic markers of CAFs, inactivating CAFs, targeting the signaling pathway activated by CAFs and its downstream factors, or preventing the interaction between tumor cells and CAFs (42, 59, 175). Here, TBX1 is linked to neoplasm.